Ardent Health (NYSE: ARDT) ex-officer plans $398K stock sale
Rhea-AI Filing Summary
Ardent Health, Inc. (ARDT) is the issuer for a planned resale of its common stock under Rule 144 by Martin Bonick, identified as a former officer and director. The notice covers 35,930 shares of common stock to be sold through Fidelity Brokerage Services LLC, with a stated aggregate market value of $398,030.92 and listing on the NYSE. The shares to be sold relate to restricted stock vesting on 06/02/2026, received from the issuer as compensation.
The filing also lists sales by Martin Bonick during the past three months: three transactions of 35,930 shares of Ardent Health common stock on 08/18/2026, 08/20/2026, and 08/25/2026, with reported aggregate sale prices of $393,481.70, $377,363.99, and $401,355.23, respectively. Fidelity Brokerage Services LLC signs the notice as attorney-in-fact for Martin Bonick.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
Rule 144 regulatory
restricted stock vesting financial
attorney-in-fact regulatory
FAQ
Which broker is handling the ARDT sales disclosed in this Form 144?
AI-generated analysis. How Rhea-AI works. Not financial advice.